Cases & Deals

Shanghai Zhenge Biotech raises $51 million in Series A round

Clients Shanghai Zhenge Biotech Co., Ltd.

Jones Day represented Shanghai Zhenge Biotech Co., Ltd., a Shanghai-based CDMO (“Contract Development and Manufacturing Organization”) company for biotech companies developing antibodies and other protein drugs, in connection with the $51 million Series A round of financing led by LYFE Capital.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.